At the present time, lipoprotein ratios including ApoB100/ApoA1, TC/HDL-C, TG/HDL-C, and LDL-C/HDL-C are used as CHD predictors in clinical practice [9]. This evidence concerns the gene APOB and coronary artery disorder.